monoisoamyl-2,3-dimercaptosuccinate has been researched along with mannitol in 1 studies
| Studies (monoisoamyl-2,3-dimercaptosuccinate) | Trials (monoisoamyl-2,3-dimercaptosuccinate) | Recent Studies (post-2010) (monoisoamyl-2,3-dimercaptosuccinate) | Studies (mannitol) | Trials (mannitol) | Recent Studies (post-2010) (mannitol) |
|---|---|---|---|---|---|
| 53 | 0 | 19 | 13,114 | 685 | 2,583 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatterjee, M; Dwivedi, VK; Khandekar, K; Mathur, N; Prasad, S; Singh, S; Tandon, SK | 1 |
1 other study(ies) available for monoisoamyl-2,3-dimercaptosuccinate and mannitol
| Article | Year |
|---|---|
Reversal of cadmium induced oxidative stress by chelating agent, antioxidant or their combination in rat.
Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Brain; Cadmium Chloride; Cadmium Poisoning; Catalase; Chelating Agents; Drug Synergism; Drug Therapy, Combination; Glutathione; Liver; Male; Malondialdehyde; Mannitol; Oxidative Stress; Rats; Succimer; Superoxide Dismutase | 2003 |